Peptide-Based Vaccines: Current Progress and Future Challenges

Cancer statistics, 2019

Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160 · see citing works

Cancer statistics, 2018

Siegel, R. L., Miller, K. D., & Jemal, A. (2018) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21442 · Cited by 16,632 · see citing works

Untangling the ErbB signalling network

Yarden, Y., & Sliwkowski, M. X. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052073 · Cited by 6,974 · see citing works

The amyloid hypothesis of Alzheimer's disease at 25 years

Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164 · see citing works

Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures

Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,970 · see citing works

Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential

Sharma, P., & Allison, J. P. (2015) · Cell · doi:10.1016/j.cell.2015.03.030 · Cited by 2,345 · see citing works

Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer

Swain, S. M., Baselga, J., Kim, S.-B., Ro, J., Semiglazov, V., Campone, M., Ciruelos, E., Ferrero, J.-M., Schneeweiss, A., Heeson, S., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1413513 · Cited by 2,164 · see citing works

Cryo-EM structures of tau filaments from Alzheimer’s disease

Fitzpatrick, A. W. P., Falcon, B., He, S., Murzin, A. G., Murshudov, G., Garringer, H. J., Crowther, R. A., Ghetti, B., Goedert, M., & Scheres, S. H. W. (2017) · Nature · doi:10.1038/nature23002 · Cited by 2,061 · cited 1× · see citing works

Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature

Nelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Tredici, K. D., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825018f7 · Cited by 2,050 · see citing works

Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer

Tran, E., Turcotte, S., Gros, A., Robbins, P. F., Lu, Y., Dudley, M. E., Wunderlich, J. R., Somerville, R. P. T., Hogan, K., Hinrichs, C. S., et al. (2014) · Science · doi:10.1126/science.1251102 · Cited by 1,710 · see citing works

Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab

Cho, H., Mason, K., Ramyar, K. X., Stanley, A. M., Gabelli, S. B., Denney, D. W., & Leahy, D. J. (2003) · Nature · doi:10.1038/nature01392 · Cited by 1,615 · see citing works

Structure of the complex between human T-cell receptor, viral peptide and HLA-A2

Garboczi, D. N., Ghosh, P., Utz, U., Fan, Q., Biddison, W. E., & Wiley, D. C. (1996) · Nature · doi:10.1038/384134a0 · Cited by 1,422 · see citing works

Epidemiology of hepatitis C virus infection

Alter, M. J. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i17.2436 · Cited by 1,349 · see citing works

Antibody Recognition of a Highly Conserved Influenza Virus Epitope

Ekiert, D. C., Bhabha, G., Elsliger, M.-A., Friesen, R. H. E., Jongeneelen, M., Throsby, M., Goudsmit, J., & Wilson, I. A. (2009) · Science · doi:10.1126/science.1171491 · Cited by 1,326 · see citing works

Mechanisms of Viral Membrane Fusion and Its Inhibition

Eckert, D. M., & Kim, P. S. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.777 · Cited by 1,283 · see citing works

The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis

Moasser, M. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210477 · Cited by 1,229 · see citing works

Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay

Parker, N. L., Turk, M. J., Westrick, E. M., Lewis, J. D., Low, P. S., & Leamon, C. P. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2004.12.026 · Cited by 1,199 · see citing works

Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex

Franklin, M. C., Carey, K. D., Vajdos, F. F., Leahy, D. J., de Vos, A. M., & Sliwkowski, M. X. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00083-2 · Cited by 1,123 · see citing works

Molecular Structure of β-Amyloid Fibrils in Alzheimer’s Disease Brain Tissue

Lu, J., Qiang, W., Yau, W., Schwieters, C. D., Meredith, S. C., & Tycko, R. (2013) · Cell · doi:10.1016/j.cell.2013.08.035 · Cited by 1,087 · see citing works

Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells

Robbins, P. F., Lu, Y., El‐Gamil, M., Li, Y. F., Gross, C. A., Gartner, J. J., Lin, J., Teer, J. K., Cliften, P. F., Tycksen, E., et al. (2013) · Nature Medicine · doi:10.1038/nm.3161 · Cited by 1,074 · see citing works

Fibril structure of amyloid-β(1–42) by cryo–electron microscopy

Gremer, L., Schölzel, D., Schenk, C., Reinartz, E., Labahn, J., Ravelli, R. B. G., Tusche, M., López‐Iglesias, C., Hoyer, W., Heise, H., et al. (2017) · Science · doi:10.1126/science.aao2825 · Cited by 1,031 · see citing works

Epidemiology and natural history of HCV infection

Hajarizadeh, B., Grebely, J., & Dore, G. J. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.107 · Cited by 994 · see citing works

Structure-based programming of lymph-node targeting in molecular vaccines

Liu, H., Moynihan, K. D., Zheng, Y., Szeto, G. L., Li, A. V., Huang, B., Egeren, D. V., Park, C., & Irvine, D. J. (2014) · Nature · doi:10.1038/nature12978 · Cited by 949 · see citing works

Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

McLellan, J. S., Pancera, M., Carrico, C., Gorman, J., Julien, J.-P., Khayat, R., Louder, R., Pejchal, R., Sastry, M., Dai, K., et al. (2011) · Nature · doi:10.1038/nature10696 · Cited by 830 · see citing works

Structure of the Gene Encoding the Immunodominant Surface Antigen on the Sporozoite of the Human Malaria Parasite Plasmodium falciparum

Dame, J. B., Williams, J. L., McCutchan, T. F., Weber, J. L., Wirtz, R. A., Hockmeyer, W. T., Maloy, W. L., Haynes, J. D., Schneider, I., Roberts, D. R., et al. (1984) · Science · doi:10.1126/science.6204383 · Cited by 712 · see citing works

A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield

Pejchal, R., Doores, K. J., Walker, L. M., Khayat, R., Huang, P.-S., Wang, S.-K., Stanfield, R. L., Julien, J.-P., Ramos, A., Crispin, M., et al. (2011) · Science · doi:10.1126/science.1213256 · Cited by 694 · see citing works

HER2: Biology, Detection, and Clinical Implications

Gutiérrez, C., & Schiff, R. (2011) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2010-0454-rar.1 · Cited by 655 · see citing works

Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys

Barouch, D. H., Whitney, J. B., Moldt, B., Klein, F., Oliveira, T. Y., Liu, J., Stephenson, K. E., Chang, H., Shekhar, K., Gupta, S., et al. (2013) · Nature · doi:10.1038/nature12744 · Cited by 644 · see citing works

A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen

Impagliazzo, A., Milder, F. J., Kuipers, H., Wagner, M. V., Zhu, X., Hoffman, R. M. B., van Meersbergen, R., Huizingh, J., Wanningen, P., Verspuij, J. W. A., et al. (2015) · Science · doi:10.1126/science.aac7263 · Cited by 591 · see citing works

Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design

Burton, D. R., & Hangartner, L. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-041015-055515 · Cited by 585 · see citing works

Proof of principle for epitope-focused vaccine design

Correia, B. E., Bates, J. T., Loomis, R. J., Baneyx, G., Carrico, C., Jardine, J. G., Rupert, P., Correnti, C., Kalyuzhniy, O., Vittal, V., et al. (2014) · Nature · doi:10.1038/nature12966 · Cited by 555 · see citing works

Complex-type N -glycan recognition by potent broadly neutralizing HIV antibodies

Mouquet, H., Scharf, L., Euler, Z., Liu, Y., Eden, C., Scheid, J. F., Halper-Stromberg, A., Gnanapragasam, P. N. P., Spencer, D. I. R., Seaman, M. S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217207109 · Cited by 549 · see citing works

Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines.

Fisk, B. A., Blevins, T. L., Wharton, J. T., & Ioannides, C. G. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.6.2109 · Cited by 544 · see citing works

HER2 expression status in diverse cancers: review of results from 37,992 patients

Yan, M., Schwaederle, M. C., Arguello, D., et al. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-015-9552-6 · Cited by 485 · see citing works

Relative Abundance of Alzheimer A Beta Amyloid Peptide Variants in Alzheimer Disease and normal Aging

Näslund, J., Schierhorn, A., Hellman, U., Lannfelt, L., Roses, A. D., Tjernberg, L. O., Silberring, J., Gandy, S. E., Winblad, B., & Greengard, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8378 · Cited by 468 · see citing works

Physiology of Folate and Vitamin B12in Health and Disease

Stover, P. J. (2004) · Nutrition Reviews · doi:10.1111/j.1753-4887.2004.tb00070.x · Cited by 464 · see citing works

Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide.

Peoples, G. E., Goedegebuure, P. S., Smith, R. W., et al. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.2.432 · Cited by 443 · see citing works

Enhanced CAR–T cell activity against solid tumors by vaccine boosting through the chimeric receptor

Ma, L., Dichwalkar, T., Chang, J. Y. H., Cossette, B. J., Garafola, D., Zhang, A. Q., Fichter, M., Wang, C., Liang, S., Silva, M., et al. (2019) · Science · doi:10.1126/science.aav8692 · Cited by 439 · see citing works

Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse Viruses

Burton, D. R., Poignard, P., Stanfield, R. L., & Wilson, I. A. (2012) · Science · doi:10.1126/science.1225416 · Cited by 416 · see citing works

Stabilization of a β-hairpin in monomeric Alzheimer's amyloid-β peptide inhibits amyloid formation

Hoyer, W., Grönwall, C., Jonsson, A., Ståhl, S., & Härd, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711731105 · Cited by 411 · see citing works

Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity

Duan, F., Duitama, J., Seesi, S. A., Ayres, C. M., Corcelli, S. A., Pawashe, A., Blanchard, T., McMahon, D., Sidney, J., Sette, A., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20141308 · Cited by 378 · see citing works

Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody

Kong, R., Xu, K. Y., Zhou, T., Acharya, P., Lemmin, T., Liu, K., Ozorowski, G., Soto, C. S., Taft, J. D., Bailer, R. T., et al. (2016) · Science · doi:10.1126/science.aae0474 · Cited by 347 · see citing works

Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120

Kong, L., Lee, J. H., Doores, K. J., Murin, C. D., Julien, J., McBride, R., Liu, Y., Marozsan, A. J., Cupo, A., Klasse, P.-J., et al. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2594 · Cited by 339 · see citing works

Trastuzumab: triumphs and tribulations

Nahta, R., & Esteva, F. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210379 · Cited by 336 · see citing works

Generation of peptide–MHC class I complexes through UV-mediated ligand exchange

Rodenko, B., Toebes, M., Hadrup, S. R., van Esch, W. J. E., Molenaar, A. M., Schumacher, T. N., & Ovaa, H. (2006) · Nature Protocols · doi:10.1038/nprot.2006.121 · Cited by 320 · see citing works

Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study

Winblad, B. G., Andreasen, N., Minthon, L., Floesser, A., Imbert, G., Dumortier, T., Maguire, R. P., Blennow, K., Lundmark, J., Staufenbiel, M., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70140-0 · Cited by 311 · see citing works

Apical membrane antigen 1 plays a central role in erythrocyte invasion by Plasmodium species

Triglia, T., Healer, J., Caruana, S. R., et al. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.02175.x · Cited by 309 · see citing works

Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes

Wang, T. T., Tan, G. S., Hai, R., Pica, N., Ngai, L., Ekiert, D. C., Wilson, I. A., García‐Sastre, A., Moran, T. M., & Palese, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013387107 · Cited by 302 · see citing works

Immuno-Oncology: Emerging Targets and Combination Therapies

Marshall, H. T., & Djamgoz, M. B. A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00315 · Cited by 299 · see citing works

Malaria Vaccines: Recent Advances and New Horizons

Draper, S., Sack, B., King, C., Nielsen, C., Rayner, J., Higgins, M., Long, C. A., & Seder, R. (2018) · Cell Host and Microbe · doi:10.1016/j.chom.2018.06.008 · Cited by 299 · see citing works

Immunotherapeutic Approaches for Alzheimer’s Disease

Wisniewski, T., & Goñi, F. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.064 · Cited by 284 · see citing works

Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1

Xu, K. Y., Acharya, P., Kong, R., Cheng, C., Chuang, G., Liu, K., Louder, M. K., O'Dell, S. J., Rawi, R., Sastry, M., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0042-6 · Cited by 284 · see citing works

Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy

Bhoj, V. G., Arhontoulis, D. C., Wertheim, G. B. W., Capobianchi, J., Callahan, C. A., Ellebrecht, C. T., Obstfeld, A. E., Lacey, S. F., Melenhorst, J. J., Nazimuddin, F., et al. (2016) · Blood · doi:10.1182/blood-2016-01-694356 · Cited by 278 · see citing works

Aβ42 assembles into specific β-barrel pore-forming oligomers in membrane-mimicking environments

Serra-Batiste, M., Ninot‐Pedrosa, M., Bayoumi, M., Gairí, M., Maglia, G., & Carulla, N. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1605104113 · Cited by 277 · see citing works

Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes

Gee, M. H., Han, A. S., Lofgren, S., Beausang, J. F., Mendoza, J. L., Birnbaum, M. E., Bethune, M. T., Fischer, S., Yang, X., Gomez, R., et al. (2017) · Cell · doi:10.1016/j.cell.2017.11.043 · Cited by 273 · see citing works

Targeting HER2 for the Treatment of Breast Cancer

Rimawi, M. F., Schiff, R., & Osborne, C. K. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-042513-015127 · Cited by 268 · see citing works

Immune Responses to HCV and Other Hepatitis Viruses

Park, S., & Rehermann, B. (2014) · Immunity · doi:10.1016/j.immuni.2013.12.010 · Cited by 264 · see citing works

Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model Tauopathy

Theunis, C., Crespo-Biel, N., Gafner, V., Pihlgren, M., López-Deber, M. P., Reis, P., Hickman, D. T., Adolfsson, O., Chuard, N., Ndao, D. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072301 · Cited by 259 · see citing works

The Disulfide Bond Structure of Plasmodium Apical Membrane Antigen-1

Hodder, A. N., Crewther, P. E., Matthew, M. L. S. M., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29446 · Cited by 259 · see citing works

First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model

Kontseková, E., Žilka, N., Kováčech, B., Novák, P., & Novák, M. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt278 · Cited by 248 · see citing works

Molecular Structure of beta-Amyloid Fibrils in Alzheimer's Disease Brain Tissue.

Lu, J., Qiang, W., Yau, W., Schwieters, C. D., Meredith, S. C., & Tycko, R. (2013) · Cell · doi:10.2210/pdb2m4j/pdb · Cited by 246 · see citing works

Molecular Cloning and Characterization of the Human Folate-binding Protein cDNA from Placenta and Malignant Tissue Culture (KB) Cells

Elwood, P. C. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63786-x · Cited by 237 · see citing works

Broadly neutralizing antibodies abrogate established hepatitis C virus infection

de Jong, Y. P., Dorner, M., Mommersteeg, M. C., Xiao, J., Balazs, A. B., Robbins, J. B., Winer, B. Y., Gerges, S., Vega, K., Labitt, R. N., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009512 · Cited by 236 · see citing works

Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes.

Brossart, P., Stuhler, G., Flad, T., et al. (1998) · PubMed · Cited by 225 · see citing works

Human Monoclonal Antibodies to a Novel Cluster of Conformational Epitopes on HCV E2 with Resistance to Neutralization Escape in a Genotype 2a Isolate

Keck, Z., Xia, J., Wang, Y., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002653 · Cited by 220 · see citing works

Efficacy and Safety Analysis of Nelipepimut-S Vaccine to Prevent Breast Cancer Recurrence: A Randomized, Multicenter, Phase III Clinical Trial

Mittendorf, E. A., Lu, B., Melisko, M., Hiller, J. A. P., Bondarenko, I., Brunt, A. M., Sergii, G., Petráková, K., & Peoples, G. E. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2867 · Cited by 214 · see citing works

Adoptive T-Cell Therapy for Cancer

Yang, J. C.-H., & Rosenberg, S. A. (2016) · Advances in immunology · doi:10.1016/bs.ai.2015.12.006 · Cited by 205 · see citing works

The epidemiology of Plasmodium falciparum gametocytes: weapons of mass dispersion

DRAKELEY, C. J., Sutherland, C. J., Bousema, T., Sauerwein, R. W., & Targett, G. A. T. (2006) · Trends in Parasitology · doi:10.1016/j.pt.2006.07.001 · Cited by 192 · see citing works

The Second-Generation Active A Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side Effects

Wießner, C., Wiederhold, K., Tissot, A. C., Frey, P., Danner, S., Jacobson, L. H., Jennings, G. T., Lüönd, R. M., Ortmann, R., Reichwald, J., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0293-11.2011 · Cited by 190 · see citing works

HER2/Neu: mechanisms of dimerization/oligomerization

Brennan, P. J., Kumogai, T., Berezov, A., Murali, R., & Greene, M. I. (2000) · Oncogene · doi:10.1038/sj.onc.1203967 · Cited by 185 · see citing works

Improving Multi-Epitope Long Peptide Vaccine Potency by Using a Strategy that Enhances CD4+ T Help in BALB/c Mice

Nazari, H. G., Tavakkol‐Afshari, J., Jaafari, M. R., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142563 · Cited by 185 · see citing works

Expression of folate transporters in human placenta and implications for homocysteine metabolism

Solanky, N., Jimenez, A. R., D'Souza, S. W., Sibley, C. P., & Glazier, J. D. (2009) · Placenta · doi:10.1016/j.placenta.2009.11.017 · Cited by 182 · see citing works

Clinical trial results of the HER‐2/ neu (E75) vaccine to prevent breast cancer recurrence in high‐risk patients

Mittendorf, E. A., Clifton, G. T., Holmes, J. P., et al. (2011) · Cancer · doi:10.1002/cncr.26574 · Cited by 174 · see citing works

Folate Receptor Type .gamma. Is Primarily a Secretory Protein Due to Lack of an Efficient Signal for Glycosylphosphatidylinositol Modification: Protein Characterization and Cell Type Specificity

Shen, F., Wu, M., Ross, J. F., Miller, D., & Ratnam, M. (1995) · Biochemistry · doi:10.1021/bi00016a042 · Cited by 168 · see citing works

Landscape of Tumor Antigens in T Cell Immunotherapy

Ilyas, S., & Yang, J. C. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501657 · Cited by 162 · see citing works

Therapeutic Vaccination of Chronic Hepatitis C Nonresponder Patients With the Peptide Vaccine IC41

Klade, C. S., Wedemeyer, H. H., Berg, T., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.058 · Cited by 156 · see citing works

Expression and Differential Polarization of the Reduced-folate Transporter-1 and the Folate Receptor α in Mammalian Retinal Pigment Epithelium

Bridges, C. C., Kekuda, R., Huang, W., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002328200 · Cited by 155 · see citing works

UB‐311, a novel UBITh ^® amyloid β peptide vaccine for mild Alzheimer's disease

Wang, C. Y., Wang, P., Chiu, M., Finstad, C. L., Lin, F., Lynn, S., Tai, Y., De Fang, X., Zhao, K., Hung, C., et al. (2017) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.03.005 · Cited by 150 · see citing works

PLASMODIUMSPOROZOITE MOLECULAR CELL BIOLOGY

Kappe, S. H. I., Buscaglia, C. A., & Nussenzweig, V. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.011603.150935 · Cited by 149 · see citing works

Safety and Immunogenicity of Multimeric-001—a Novel Universal Influenza Vaccine

Atsmon, J., Kate-Ilovitz, E., Shaikevich, D., et al. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-011-9632-5 · Cited by 149 · see citing works

Role of the folate receptor in ovarian cancer treatment: evidence, mechanism, and clinical implications

Vergote, I. B., Marth, C., & Coleman, R. L. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-014-9539-8 · Cited by 148 · see citing works

FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer's disease

Novak, P., Schmidt, R., Kontsekova, E., Kovacech, B., Smolek, T., Katina, S., Fialova, L., Prcina, M., Parrak, V., Dal-Bianco, P., et al. (2018) · Alzheimer's Research & Therapy · doi:10.1186/s13195-018-0436-1 · Cited by 147 · see citing works

A Retrospective Examination of Sporozoite- and Trophozoite-Induced Infections with Plasmodium Falciparum: Development of Parasitologic and Clinical Immunity during Primary Infection

Collins, W. E., & Jeffery, G. M. (1999) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/tropmed.1999.61-04 · Cited by 146 · see citing works

Long-term treatment with active Aβ immunotherapy with CAD106 in mild Alzheimer’s disease

Farlow, M. R., Andreasen, N., Riviere, M., Voštiar, I., Vitaliti, A., Sóvágó, J., Caputo, A., Winblad, B. G., & Graf, A. (2015) · Alzheimer s Research & Therapy · doi:10.1186/s13195-015-0108-3 · Cited by 145 · see citing works

Deaths from Alzheimer’s Disease — United States, 1999–2014

Taylor, C. A., Greenlund, S. F., McGuire, L. C., Lu, H., & Croft, J. B. (2017) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6620a1 · Cited by 144 · see citing works

Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: A randomized, placebo controlled trial for dose optimization in 128 healthy subjects

Firbas, C., Jilma, B., Tauber, E., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.03.009 · Cited by 143 · see citing works

Membrane Anchored Immunostimulatory Oligonucleotides for In Vivo Cell Modification and Localized Immunotherapy

Liu, H., Kwong, B., & Irvine, D. J. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201101266 · Cited by 142 · see citing works

Active Aβ immunotherapy CAD106 in Alzheimer's disease: A phase 2b study

Vandenberghe, R. R., Riviere, M., Caputo, A., Sóvágó, J., Maguire, R. P., Farlow, M. R., Marotta, G., Sánchez‐Valle, R., Scheltens, P., Ryan, J. M., et al. (2016) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2016.12.003 · Cited by 141 · see citing works

Dendritic cells pulsed with HER-2/neu-derived peptides can induce specific T-cell responses in patients with gastric cancer.

Kono, K., Takahashi, A., Sugai, H., Fujii, H., Choudhury, A., Kiessling, R. W., & Matsumoto, Y. (2002) · PubMed · Cited by 137 · see citing works

The Selection Landscape of Malaria Parasites

Mackinnon, M. J., & Marsh, K. (2010) · Science · doi:10.1126/science.1185410 · Cited by 137 · see citing works

Cell biology and immunology of malaria

Hafalla, J. C. R., Silvie, O., & Matuschewski, K. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00988.x · Cited by 136 · see citing works

Modification of MHC Anchor Residues Generates Heteroclitic Peptides That Alter TCR Binding and T Cell Recognition

Cole, D. K., Edwards, E. S. J., Wynn, K. K., Clement, M., Miles, J. J., Ladell, K., Ekeruche, J., Emma Gostick, D., Adams, K. J., Skowera, A., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000629 · Cited by 128 · see citing works

Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives

Krasniqi, E., Barchiesi, G., Pizzuti, L., Mazzotta, M., Venuti, A., Maugeri‐Saccà, M., Sanguineti, G., Massimiani, G., Sergi, D., Carpano, S., et al. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0798-2 · Cited by 128 · see citing works

HIV-1 and influenza antibodies: seeing antigens in new ways

Kwong, P. D., & Wilson, I. A. (2009) · Nature Immunology · doi:10.1038/ni.1746 · Cited by 127 · see citing works

Dysregulation of cellular signaling by HER2 in breast cancer

Zhou, B. P. (2003) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.08.006 · Cited by 127 · see citing works

Antibody 27F3 Broadly Targets Influenza A Group 1 and 2 Hemagglutinins through a Further Variation in VH1-69 Antibody Orientation on the HA Stem

Lang, S., Xie, J., Zhu, X., Wu, N. C., Lerner, R. A., & Wilson, I. A. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.084 · Cited by 123 · see citing works

The path of malaria vaccine development: challenges and perspectives

Arama, C., & Troye‐Blomberg, M. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12223 · Cited by 116 · see citing works

A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study

Wiedermann, U., Wiltschke, C., Jasińska, J., Kundi, M., Zurbriggen, R., Garner‐Spitzer, E., Bartsch, R., Steger, G. G., Pehamberger, H., Scheiner, O., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0666-9 · Cited by 115 · see citing works

Immunogenicity, Efficacy, Safety, and Mechanism of Action of Epitope Vaccine (Lu AF20513) for Alzheimer's Disease: Prelude to a Clinical Trial

Davtyan, H., Ghochikyan, A., Petrushina, I., Hovakimyan, A., Davtyan, A., Poghosyan, A., Marleau, A. M., Movsesyan, N., Kiyatkin, A., Rasool, S., et al. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.4672-12.2013 · Cited by 112 · see citing works

Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence

Mittendorf, E. A., Ardavanis, A. S., Litton, J. K., Shumway, N. M., Hale, D. F., Murray, J. L., Perez, S. A., Ponniah, S., Baxevanis, C. N., Papamichail, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11751 · Cited by 112 · see citing works

Prevention of mammary tumors with a chimeric HER-2 B-cell epitope peptide vaccine.

Dakappagari, N. K., Douglas, D., Triozzi, P. L., et al. (2000) · PubMed · Cited by 112 · see citing works

Identification of structural determinants on tau protein essential for its pathological function: novel therapeutic target for tau immunotherapy in Alzheimer’s disease

Kontsekova, E., Zilka, N., Kovacech, B., Skrabana, R., & Novak, M. (2014) · Alzheimer's Research & Therapy · doi:10.1186/alzrt277 · Cited by 112 · see citing works

A Multipeptide Vaccine is Safe and Elicits T-cell Responses in Participants With Advanced Stage Ovarian Cancer

Chianese‐Bullock, K. A., Irvin, W. P., Petroni, G. R., Murphy, C., Smolkin, M. E., Olson, W. C., Coleman, E. J., Boerner, S. A., Nail, C. J., Neese, P. Y., et al. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31816dad10 · Cited by 111 · see citing works

Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer’s disease: a randomised, double-blind, placebo-controlled, phase I trial

Lacosta, A.-M., Pascual-Lucas, M., Pesini, P., Casabona, D., Pérez-Grijalba, V., Marcos-Campos, I., Sarasa, L., Canudas, J., Badi, H., Monleón, I., et al. (2018) · Alzheimer's Research & Therapy · doi:10.1186/s13195-018-0340-8 · Cited by 111 · see citing works

Paradoxical Impact of Two Folate Receptors, FRα and RFC, in Ovarian Cancer: Effect on Cell Proliferation, Invasion and Clinical Outcome

Siu, M. K. Y., Kong, D. S. H., Chan, H. Y., Wong, E. S. Y., Ip, P. P. C., Jiang, L., Ngan, H., Le, X., & Cheung, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047201 · Cited by 108 · see citing works

Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells

Tanaka, M., Tashiro, H., Omer, B. A., Lapteva, N., Ando, J., Ngo, M. C., Mehta, B., Dotti, G., Kinchington, P. R., Leen, A. M., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2138 · Cited by 104 · see citing works

Folate Receptor Alpha Peptide Vaccine Generates Immunity in Breast and Ovarian Cancer Patients

Kalli, K. R., Block, M. S., Kasi, P. M., Erskine, C. L., Hobday, T. J., Dietz, A. B., Padley, D. J., Gustafson, M. P., Shreeder, B., Puglisi-Knutson, D., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2499 · Cited by 101 · see citing works

Clearance of Amyloid-Beta in Alzheimer’s Disease: Shifting the Action Site from Center to Periphery

Liu, Y.-H., Wang, Y.-R., Xiang, Y., Zhou, H.-D., Giunta, B., Mañucat-Tan, N. B., Tan, J., Zhou, X.-F., & Wang, Y.-J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8694-9 · Cited by 99 · see citing works

Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide

Alam, S. M., Aussedat, B., Vohra, Y., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aai7521 · Cited by 99 · see citing works

Site-specific UBITh® amyloid-β vaccine for immunotherapy of Alzheimer's disease

Wang, C. Y., Finstad, C. L., Walfield, A. M., Sia, C., Sokoll, K. K., Chang, T.-Y., Fang, X. D., Hung, C. H., Hutter-Paier, B., & Windisch, M. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.031 · Cited by 98 · see citing works

Structural insights into key sites of vulnerability on HIV ‐1 Env and influenza HA

Julien, J., Lee, P. S., & Wilson, I. A. (2012) · Immunological Reviews · doi:10.1111/imr.12005 · Cited by 97 · see citing works

Structural Basis of HCV Neutralization by Human Monoclonal Antibodies Resistant to Viral Neutralization Escape

Krey, T., Meola, A., Keck, Z., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003364 · Cited by 96 · see citing works

Peptide exchange on MHC-I by TAPBPR is driven by a negative allostery release cycle

McShan, A. C., Natarajan, K., Kumirov, V. K., et al. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0096-2 · Cited by 96 · see citing works

Induction of Parasite Growth-Inhibitory Antibodies by a Virosomal Formulation of a Peptidomimetic of Loop I from Domain III of Plasmodium falciparum Apical Membrane Antigen 1

Mueller, M. S., Renard, A., Boato, F., et al. (2003) · Infection and Immunity · doi:10.1128/iai.71.8.4749-4758.2003 · Cited by 95 · see citing works

Priming by a novel universal influenza vaccine (Multimeric-001)—A gateway for improving immune response in the elderly population

Atsmon, J., Caraco, Y., Ziv-Sefer, S., Shaikevich, D., Abramov, E., Volokhov, I., Bruzil, S., Haima, K. Y., Gottlieb, T. M., & Ben-Yedidia, T. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.08.031 · Cited by 88 · see citing works

Ten Years of Tau-Targeted Immunotherapy: The Path Walked and the Roads Ahead

Novak, P., Kontsekova, E., Zilka, N., & Novak, M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00798 · Cited by 87 · cited 1× · see citing works

Diversity of the vaccine candidate AMA-1 of Plasmodium falciparum

Marshall, V. A. (1996) · Molecular and Biochemical Parasitology · doi:10.1016/0166-6851(96)02583-2 · Cited by 87 · see citing works

Structural flexibility at a major conserved antibody target on hepatitis C virus E2 antigen

Kong, L., Lee, D. E., Kadam, R. U., Liu, T., Giang, E., Nieusma, T., Garcés, F., Tzarum, N., Woods, V. L., Ward, A. B., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609780113 · Cited by 86 · see citing works

Vaccines Against Malaria

Ouattara, A., & Laurens, M. B. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu954 · Cited by 85 · see citing works

Immunostimulating reconstituted influenza virosomes

Zurbriggen, R. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00541-8 · Cited by 84 · see citing works

Sequence-independent Control of Peptide Conformation in Liposomal Vaccines for Targeting Protein Misfolding Diseases

Hickman, D. T., López-Deber, M. P., Ndao, D. M., Silva, A. B., Nand, D., Pihlgren, M., Giriens, V., Madani, R., St-Pierre, A., Karastaneva, H., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.186338 · Cited by 83 · see citing works

Phase I Active Immunotherapy With Combination of Two Chimeric, Human Epidermal Growth Factor Receptor 2, B-Cell Epitopes Fused to a Promiscuous T-Cell Epitope in Patients With Metastatic and/or Recurrent Solid Tumors

Kaumaya, P. T. P., Foy, K. C., Garrett, J. T., Rawale, S. V., Vicari, D., Thurmond, J. M., Lamb, T., Mani, A., Kane, Y., Balint, C. R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.3883 · Cited by 83 · see citing works

X-ray Crystallographic Structures of a Trimer, Dodecamer, and Annular Pore Formed by an Aβ17–36 β-Hairpin

Kreutzer, A. G., Hamza, I. L., Spencer, R. K., & Nowick, J. S. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b01332 · Cited by 83 · see citing works

Safety issues from a Phase 3 clinical trial of a live-attenuated chimeric yellow fever tetravalent dengue vaccine

Halstead, S. B. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1445448 · Cited by 82 · see citing works

The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development

Cashman, S. B., Marsden, B. D., & Dustin, L. B. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00550 · Cited by 80 · see citing works

Variation in relapse frequency and the transmission potential of Plasmodium vivax malaria

White, M., Shirreff, G., Karl, S., et al. (2016) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2016.0048 · Cited by 78 · see citing works

Evaluation of the HER2/neu‐derived peptide GP2 for use in a peptide‐based breast cancer vaccine trial

Mittendorf, E. A., Storrer, C. E., Foley, R. J., et al. (2006) · Cancer · doi:10.1002/cncr.21849 · Cited by 77 · see citing works

T-Cell Immunity to the Folate Receptor Alpha Is Prevalent in Women With Breast or Ovarian Cancer

Knutson, K. L., Krco, C. J., Erskine, C. L., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.9311 · Cited by 75 · see citing works

A Chimeric Multi-Human Epidermal Growth Factor Receptor-2 B Cell Epitope Peptide Vaccine Mediates Superior Antitumor Responses

Dakappagari, N. K., Pyles, J. A., Parihar, R., Carson, W. E., Young, D. C., & Kaumaya, P. T. P. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.8.4242 · Cited by 73 · see citing works

Stabilization, Assembly, and Toxicity of Trimers Derived from Aβ

Kreutzer, A. G., Yoo, S., Spencer, R. K., et al. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b11748 · Cited by 71 · see citing works

HER2 therapy. HER2 (ERBB2): functional diversity from structurally conserved building blocks

Landgraf, R. (2007) · Breast Cancer Research · doi:10.1186/bcr1633 · Cited by 70 · see citing works

Virosome-Formulated Plasmodium falciparum AMA-1 & CSP Derived Peptides as Malaria Vaccine: Randomized Phase 1b Trial in Semi-Immune Adults & Children

Cech, P. G., Aebi, T., Abdallah, M. S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022273 · Cited by 69 · see citing works

CMVpp65 Vaccine Enhances the Antitumor Efficacy of Adoptively Transferred CD19-Redirected CMV-Specific T Cells

Wang, X., Wong, C. W., Urak, R. Z., Mardiros, A., Budde, L. E., Chang, W.-C., Thomas, S. H., Brown, C. E., Rosa, C. L., Diamond, D. J., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2920 · Cited by 69 · see citing works

Phase I Immunotherapy Trial with Two Chimeric HER-2 B-Cell Peptide Vaccines Emulsified in Montanide ISA 720VG and Nor-MDP Adjuvant in Patients with Advanced Solid Tumors

Bekaii‐Saab, T., Wesolowski, R., Ahn, D. H., Wu, C. S.-Y., Mortazavi, A., Lustberg, M. B., Ramaswamy, B., Fowler, J. M., Wei, L., Overholser, J. P., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3997 · Cited by 67 · see citing works

HCV-Specific T Cell Responses During and After Chronic HCV Infection

Luxenburger, H., Neumann-Haefelin, C., Thimme, R., & Boettler, T. (2018) · Viruses · doi:10.3390/v10110645 · Cited by 64 · see citing works

Structure of a High-affinity “Mimotope” Peptide Bound to HIV-1-neutralizing Antibody b12 Explains its Inability to Elicit gp120 Cross-reactive Antibodies

Saphire, E. O., Montero, M., Menéndez, A., et al. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.01.060 · Cited by 64 · see citing works

Structure-Based Design of Hepatitis C Virus Vaccines That Elicit Neutralizing Antibody Responses to a Conserved Epitope

Pierce, B. G., Boucher, E. N., Piepenbrink, K. H., Ejemel, M., Rapp, C. A., Thomas, W. D., Sundberg, E. J., Weng, Z., & Wang, Y. (2017) · Journal of Virology · doi:10.1128/jvi.01032-17 · Cited by 63 · see citing works

Combinatorial peptide libraries as an alternative approach to the identification of ligands for tumor-reactive cytolytic T lymphocytes.

Pinilla, C., Rubio‐Godoy, V., Dutoit, V., et al. (2001) · PubMed · Cited by 62 · see citing works

Plasmodium falciparum AMA-1 erythrocyte binding peptides implicate AMA-1 as erythrocyte binding protein

Urquiza, M., Suárez, J., Cárdenas, C., et al. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00185-7 · Cited by 61 · see citing works

A Randomized Placebo-Controlled Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated Synthetic Peptides in Healthy Adult Volunteers

Genton, B., Pluschke, G., Degen, L. P., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001018 · Cited by 60 · see citing works

Broadly neutralizing antibodies from an individual that naturally cleared multiple hepatitis C virus infections uncover molecular determinants for E2 targeting and vaccine design

Keck, Z., Pierce, B. G., Lau, P., et al. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007772 · Cited by 60 · see citing works

Positional Scanning-Synthetic Peptide Library-Based Analysis of Self- and Pathogen-Derived Peptide Cross-Reactivity with Tumor-Reactive Melan-A-Specific CTL

Rubio‐Godoy, V., Dutoit, V., Zhao, Y., Simon, R. M., Guillaume, P., Houghten, R. A., Romero, P. J., Cerottini, J., Pinilla, C., & Valmori, D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5696 · Cited by 59 · see citing works

Vaccine implications of folate binding protein, a novel cytotoxic T lymphocyte-recognized antigen system in epithelial cancers.

Peoples, G. E., Anderson, B. W., Lee, T. V., et al. (1999) · PubMed · Cited by 59 · see citing works

Engineered Dengue Virus Domain III Proteins Elicit Cross-Neutralizing Antibody Responses in Mice

Frei, J. C., Wirchnianski, A. S., Govero, J., Vergnolle, O., Dowd, K. A., Pierson, T. C., Kielian, M. C., Girvin, M. E., Diamond, M., & Lai, J. R. (2018) · Journal of Virology · doi:10.1128/jvi.01023-18 · Cited by 59 · see citing works

Novel Engineered Trastuzumab Conformational Epitopes Demonstrate In Vitro and In Vivo Antitumor Properties against HER-2/neu

Garrett, J. T., Rawale, S. V., Allen, S. D., Phillips, G. S., Forni, G., Morris, J. C., & Kaumaya, P. T. P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.7120 · Cited by 58 · see citing works

Inhibition of tumor cell growth by antibodies induced after vaccination with peptides derived from the extracellular domain of Her‐2/neu

Jasińska, J., Wagner, S. N., Radauer, C., Sedivy, R., Brodowicz, T., Wiltschke, C., Breiteneder, H., Pehamberger, H., Scheiner, O., Wiedermann, U., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11485 · Cited by 58 · see citing works

Folate status in various pathophysiological conditions

Wani, N. A., Hamid, A., & Kaur, J. (2008) · IUBMB Life · doi:10.1002/iub.133 · Cited by 58 · see citing works

Synthetic peptides as antigens for the detection of humoral immunity to Plasmodium falciparum sporozoites

Zavala, F. P., Tam, J. P., & Masuda, A. (1986) · Journal of Immunological Methods · doi:10.1016/0022-1759(86)90432-1 · Cited by 57 · see citing works

Immunogenicity and safety of different injection routes and schedules of IC41, a Hepatitis C virus (HCV) peptide vaccine

Firbas, C., Boehm, T., Buerger, V., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2009.12.072 · Cited by 57 · see citing works

Consistent elicitation of cross-clade HIV-neutralizing responses achieved in guinea pigs after fusion peptide priming by repetitive envelope trimer boosting

Cheng, C., Xu, K. Y., Kong, R., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215163 · Cited by 54 · see citing works

Ovarian cancer-associated lymphocyte recognition of folate binding protein peptides

Peoples, G. E., Anderson, B. W., Fisk, B. A., et al. (1998) · Annals of Surgical Oncology · doi:10.1007/bf02303486 · Cited by 53 · see citing works

Peptide Vaccines of the HER-2/neu Dimerization Loop Are Effective in Inhibiting Mammary Tumor Growth In Vivo

Allen, S. D., Garrett, J. T., Rawale, S. V., Jones, A. L., Phillips, G. S., Forni, G., Morris, J. C., Oshima, R. G., & Kaumaya, P. T. P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.472 · Cited by 52 · see citing works

A flexible MHC class I multimer loading system for large-scale detection of antigen-specific T cells

Luimstra, J. J., Garstka, M. A., Roex, M. C. J., Redeker, A., Janssen, G. M. C., van Veelen, P. A., Arens, R., Falkenburg, J. H. F., Neefjes, J., & Ovaa, H. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20180156 · Cited by 51 · see citing works

Synthetic Three-Component HIV-1 V3 Glycopeptide Immunogens Induce Glycan-Dependent Antibody Responses

Cai, H., Orwenyo, J., Giddens, J. P., Yang, Q., Zhang, R., LaBranche, C. C., Montefiori, D. C., & Wang, L. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.09.005 · Cited by 51 · see citing works

Optimal dose and schedule of an HER‐2/neu (E75) peptide vaccine to prevent breast cancer recurrence

Holmes, J. P., Gates, J. D., Benavides, L. C., et al. (2008) · Cancer · doi:10.1002/cncr.23772 · Cited by 50 · see citing works

Use of booster inoculations to sustain the clinical effect of an adjuvant breast cancer vaccine

Holmes, J. P., Clifton, G. T., Patil, R., Benavides, L. C., Gates, J. D., Stojadinovic, A., Mittendorf, E. A., Ponniah, S., & Peoples, G. E. (2010) · Cancer · doi:10.1002/cncr.25586 · Cited by 49 · see citing works

A Step Further in Understanding the Biology of the Folate Receptor in Ovarian Carcinoma

Bagnoli, M., Canevari, S., Figini, M., et al. (2003) · Gynecologic Oncology · doi:10.1006/gyno.2002.6705 · Cited by 48 · see citing works

Crystal structure of an NPNA-repeat motif from the circumsporozoite protein of the malaria parasite Plasmodium falciparum

Ghasparian, A., Moehle, K., Linden, A., et al. (2005) · Chemical Communications · doi:10.1039/b510812h · Cited by 48 · see citing works

Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine

van Doorn, E., Liu, H., Ben-Yedidia, T., Hassin, S., Visontai, I., Norley, S., Frijlink, H. W., & Hak, E. (2017) · Medicine · doi:10.1097/md.0000000000006339 · Cited by 47 · see citing works

Expression of folate receptor alpha in the mammalian retinol pigmented epithelium and retina.

Smith, S. B., Kekuda, R., Gu, X., et al. (1999) · PubMed · Cited by 44 · see citing works

Enhanced and long term immunogenicity of a Her-2/neu multi-epitope vaccine conjugated to the carrier CRM197 in conjunction with the adjuvant Montanide

Tobias, J., Jasińska, J., Baier, K., Kundi, M., Ede, N. J., Zielinski, C. C., & Wiedermann, U. (2017) · BMC Cancer · doi:10.1186/s12885-017-3098-7 · Cited by 44 · see citing works

Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP)

Sedegah, M., Kim, Y., Ganeshan, H. D., Huang, J., Belmonte, M., Abot, E. N., Banania, J. G., Farooq, F., McGrath, S. M., Peters, B., et al. (2013) · Malaria Journal · doi:10.1186/1475-2875-12-185 · Cited by 41 · see citing works

Multivalent Antigen Presentation Enhances the Immunogenicity of a Synthetic Three-Component HIV‑1 V3 Glycopeptide Vaccine

Cai, H., Zhang, R., Orwenyo, J., Giddens, J. P., Yang, Q., LaBranche, C. C., Montefiori, D. C., & Wang, L. (2018) · ACS Central Science · doi:10.1021/acscentsci.8b00060 · Cited by 40 · see citing works

Structure-Activity-Based Design of a Synthetic Malaria Peptide Eliciting Sporozoite Inhibitory Antibodies in a Virosomal Formulation

Okitsu, S. L., Kienzl, U., Moehle, K., et al. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.04.008 · Cited by 39 · see citing works

Adjuvant HER2/Neu Peptide Cancer Vaccines in Breast Cancer

Clifton, G. T., Mittendorf, E. A., & Peoples, G. E. (2015) · Immunotherapy · doi:10.2217/imt.15.81 · Cited by 39 · see citing works

Neurofibrillary Tangles of Aβx-40 in Alzheimer’s Disease Brains

Lacosta, A.-M., Insua, D., Badi, H., Pesini, P., & Sarasa, M. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170163 · Cited by 35 · see citing works

Systematic Synthesis and Binding Study of HIV V3 Glycopeptides Reveal the Fine Epitopes of Several Broadly Neutralizing Antibodies

Orwenyo, J., Cai, H., Giddens, J. P., Amin, M. A., Toonstra, C., & Wang, L. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00319 · Cited by 30 · see citing works

Sustained viral load reduction in treatment-naive HCV genotype 1 infected patients after therapeutic peptide vaccination

Klade, C. S., Schuller, E., Boehm, T., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.02.070 · Cited by 28 · see citing works

Site-specific peptide vaccines for immunotherapy and immunization against chronic diseases, cancer, infectious diseases, and for veterinary applications

Wang, C. C., & Walfield, A. M. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.007 · Cited by 26 · see citing works

Delayed tumor onset and reduced tumor growth progression after immunization with a Her-2/neu multi-peptide vaccine and IL-12 in c-neu transgenic mice

Wagner, S. N., Jasińska, J., Breiteneder, H., et al. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9469-4 · Cited by 25 · see citing works

Conditional Trimerization and Lytic Activity of HIV-1 gp41 Variants Containing the Membrane-Associated Segments

Dai, Z., Tao, Y., Liu, N., Brenowitz, M. D., Girvin, M. E., & Lai, J. R. (2015) · Biochemistry · doi:10.1021/bi501376f · Cited by 24 · see citing works

Effective Treatment of Staphylococcal Enterotoxin B Aerosol Intoxication in Rhesus Macaques by Using Two Parenterally Administered High-Affinity Monoclonal Antibodies

Verreault, D., Ennis, J., Whaley, K. J., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02049-18 · Cited by 23 · see citing works

Broadening CD4+and CD8+T Cell Responses against Hepatitis C Virus by Vaccination with NS3 Overlapping Peptide Panels in Cross-Priming Liposomes

Filskov, J., Mikkelsen, M., Hansen, P. B., et al. (2017) · Journal of Virology · doi:10.1128/jvi.00130-17 · Cited by 21 · see citing works

Immobilization by Surface Conjugation of Cyclic Peptides for Effective Mimicry of the HCV-Envelope E2 Protein as a Strategy toward Synthetic Vaccines

Meuleman, T. J., Dunlop, J. I., Owsianka, A. M., et al. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00755 · Cited by 21 · see citing works

Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizations

Akapirat, S., Karnasuta, C., Vasan, S., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196397 · Cited by 19 · see citing works

Combinations of Monoclonal Antibodies to Anthrax Toxin Manifest New Properties in Neutralization Assays

Pohl, M. A., Rivera, J., Nakouzi, A. S., et al. (2013) · Infection and Immunity · doi:10.1128/iai.01328-12 · Cited by 18 · see citing works

A Single Human Monoclonal Antibody That Confers Total Protection From Tetanus

Arunachalam, B., Ghosh, S. C., Talwar, G. P., et al. (1992) · Hybridoma · doi:10.1089/hyb.1992.11.165 · Cited by 16 · see citing works

Protein engineering strategies for the development of viral vaccines and immunotherapeutics

Koellhoffer, J. F., Higgins, C. D., & Lai, J. R. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.10.014 · Cited by 16 · see citing works

Platform technology to generate broadly cross‐reactive antibodies to α‐helical epitopes in hemagglutinin proteins from influenza A viruses

Jiang, Z., Gera, L., Mant, C. T., Hirsch, B., Yan, Z., Shortt, J., Pollock, D. D., Qian, Z., Holmes, K. V., & Hodges, R. S. (2016) · Biopolymers · doi:10.1002/bip.22808 · Cited by 10 · see citing works

Phenotypic analysis of the murine CD4-related glycoprotein, CD223 (LAG-3)

(2002) · doi:10.1002/1521-4141(200208)32:8

Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials

Xie, X., Yu, T., Li, X., Zhang, N., Foster, L. J., Peng, C., Huang, W., & He, G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01589-z · Cited by 396 · see citing works

Targeting aging and age-related diseases with vaccines

Wu, R., Sun, F., Zhang, W., Ren, J., & Liu, G.-H. (2024) · Nature Aging · doi:10.1038/s43587-024-00597-0 · Cited by 66 · see citing works

Induction of High Levels of Antibodies Recognizing the Neutralizing Epitope ELDKWA and the D- or K-Position-Mutated Epitopes by Candidate Epitope Vaccines against HIV-1

Xiao, Y. Q., Dong, X., & Chen, Y. (2000) · International Archives of Allergy and Immunology · doi:10.1159/000024411 · Cited by 7 · see citing works

Mapping of 10 epitopes on bovine herpesvirus type 1 glycoproteins gl and glll

Fitzpatrick, D. R., Redmondz, M. J., ATTAH‐POKU, S. K., et al. (1990) · Virology · doi:10.1016/0042-6822(90)90239-n · Cited by 34 · see citing works

Antigenicity and Predefined Specificities of the Multi-Epitope Vaccine in Candidate Consisting of Neutralizing Epitope and Mutated Epitopes Suggested a New Way against HIV-1 Mutation

Tian, H. (2001) · Immunobiology · doi:10.1078/0171-2985-00053 · Cited by 7 · see citing works

Identification of linear B cell epitopes on VP1 and VP2 proteins of Senecavirus A (SVA) using monoclonal antibodies

Fan, H., Zhu, H., Li, S., et al. (2020) · Veterinary Microbiology · doi:10.1016/j.vetmic.2020.108753 · Cited by 34 · see citing works

HLA-DR antibody epitopes.

Cai, J., Kohanof, S., & Terasaki, P. I. (2006) · PubMed · Cited by 14 · see citing works